Liquid-based cytology (LBC) processing technology enables specimens, rather than smearing on the slides, to be collected, preserved and transported. Specimens are then processed in the laboratory using different instrumentation, automation, and solutions, and the result is a thin layer (mono-layer) of cells on the slide, which is easier to evaluate. So, the LBC processing technology preserves and prepares specimens for clear unobstructed analysis by pathologists or cytologists. However, the first generation LBC processing technology suffers from high cost per patient due to the use of expensive instruments and automation. The high cost of automation coupled with the high cost maintenance, filters, and other devices prevented the first generation LBCs to be implemented in many developing countries as well as developed countries where affordability and accessibility are a challenge.

At chemQ bioscience, we have developed a new second-generation LBC technology that does not use any expensive or complex automated instrumentation but utilizes equipment which is available in most clinical laboratories.  We use “Green Chemistry” technology to formulate new user and environmentally friendly products that contain no hazardous chemicals such as formalin. The new processing kits bring down the costs of performing LBC screening and make them ideal for use in any laboratory around the world where affordability and accessibility are a challenge.